🙌 CancerX Moonshot has officially come to an end. 📚 We have learned about patient engagement strategies with Savvy Cooperative, discussed Advocate Health’s perspective on the future of health with Rasu Shrestha MD MBA, explored bringing cancer care closer to home with Ruben Mesa, MD from Atrium Health, and delved into data strategy and partnership approaches with Tim Arnold from Advocate Health. Michael K. Giannopoulos and Matthew Powers from Dell Technologies, our champion, guided us through best practices in AI and data management, while Andrea Downing from Light Collective provided insights into AI guardrails. We also learned about reimbursement strategy with Foley & Lardner LLP, and heard from American Cancer Society BrightEdge Fund about their work in impact investing. Finally, we had the chance to e-meet with representatives from the Office of the National Coordinator for Health IT, which manages health IT policies and programs for the U.S. Federal Government. Christa Bogdanow from MassChallenge and Beth Andrews from Dell Technologies guided us through the entire program and supported us in every aspect we needed. 🚀 What an incredible journey! Thank you all for your time and efforts in helping startups build the next era of healthcare!
The Blue Box Biomedical Solutions
Fabricación de equipo médico
Barcelona, Catalonia 2626 seguidores
Breast cancer prevention, as easy as a pregnancy test.
Sobre nosotros
Women lack reliable breast cancer (BC) screening methods, as 50% of BCs are detected in a late-stage. At The Blue Box, we've developed a radiation-free, pain-free, low-cost device detecting BC in urine with 88.33%. This outperforms mammography by 15% across all age groups and by 30% for women under 50. By 2025, we aim to introduce this solution in gynecology clinics through a software-driven business model.
- Sitio web
-
http://thebluebox.ai
Enlace externo para The Blue Box Biomedical Solutions
- Sector
- Fabricación de equipo médico
- Tamaño de la empresa
- De 2 a 10 empleados
- Sede
- Barcelona, Catalonia
- Tipo
- De financiación privada
- Fundación
- 2021
- Especialidades
- Artificial intelligence, Breast cancer prevention, Machine Learning, Data gathering, Deep learning y Biomedical engineering
Ubicaciones
-
Principal
C. Pasqual i Vila
Barcelona, Catalonia 08029, ES
Empleados en The Blue Box Biomedical Solutions
-
Lidia Navarro Farré, PhD
Building a urine-based Breast Cancer test – pain-free, radiation-free
-
Judit Giró Benet
Building a urine-based breast cancer test with a sensitivity of 88%
-
Júlia Solana Balaguer, PhD
Scientific & Clinical Lead | The Blue Box |📍Barcelona
-
Andrea Avila Cardozo
Trilingual EA & Project Manager
Actualizaciones
-
👁️ Check out the latest episode of BioEmprendedores where our CEO, Judit Giró Benet, and the CEO of Perdigó Medical's, Arnau Perdigó-Oliveras were interviewed. 💫 BioEmprendedores is the go-to #podcast for biotech, health and medtech entrepreneurship hosted by Rosendo Garganta & Oscar Porcel ⬇️ We chatted about innovating in the medical industry, the need of understanding of the product's clinical value and to have a strong positioning strategy, and great partners—like we do with Perdigó Medical. 🎉 Thanks for having us!! Youtube: https://lnkd.in/dCxG8tqR Ivoox: https://lnkd.in/dhyYtkYs Spotify: https://lnkd.in/d5kDM_Q4
-
🧐🧠Understanding how The Blue Box can fit into other healthcare systems in Europe is one of our main objectives for 2024. Happy to participate in the first edition in Spain from one of the top Medtech events in France! #HealthcareInnovation #HealthTech #MedicalDevices
🚀 Nous avons le plaisir de vous annoncer les 9 finalistes du Concours de l’Innovation 2024 ! Félicitations aux start-ups qui auront l'honneur de présenter leurs projets lors de la 1ère édition de Medi'Nov Connection Spain : - Enrique Llaudet Carles, Ephion Health - Javier Jiménez, Kriba - Nuria Antolí, NURA TECHNOLOGY SL - Judit Giró Benet, The Blue Box Biomedical Solutions - Eduardo W. Jørgensen de Vizcarrondo, Medicsen - Laetitia Lebert, Medinbox - Szilvia Endrényi, Rethink Medical SL. - Julien FINCI, Aspivix - Nathalie Vandenbroucke, Dendris Ne manquez pas leurs présentations le mercredi 26 juin, de 17h00 à 18h00, au WTC de Barcelone ! 🚀 We are delighted to announce the 9 finalists in the 2024 Innovation Competition ! Congratulations to the start-ups who will have the honour of presenting their projects at the 1st edition of Medi'Nov Connection Spain. Don't miss their presentations on Wednesday 26 June, from 17:00 to 18:00, at the WTC of Barcelona ! #Innovation #Medtech #Startup
-
🎖️ It is an honor to receive recognition from one of the most consolidated banks in Spain as one of the most disruptive companies in the 'Bienestar del Mañana/ Well-being of tomorrow' challenge.
Un año más, entregamos los galardones de la fase de Retos de los Premios EmprendeXXI🏆 que premian las mejores soluciones a los principales desafíos de la sociedad actual desde una perspectiva innovadora. Las start-ups premiadas en esta 17.ª edición de los Premios EmprendeXXI han sido NIGAL Nova Industria Galega, Gravity Wave, The Blue Box Biomedical Solutions, Showee , EONESIA, NUWE, Nidus Lab, PandaGo, Cafler, Colibid, Hotel Treats, Hotel eCommerce y Oratrex. ¡Enhorabuena a todas las start-ups ganadoras de esta 17ª edición! 🎉👏 #PremiosEmprendeXXI
-
🤞 A significant breakthrough in the detection of breast cancer, which increasingly affects younger women.
🙌Catalunya expands Breast Cancer screening ages!🙌 📅Starting in 2025, Catalunya will lower the age for breast cancer screenings from 50 to 45, extending up to 74 years old! This change aligns with the U.S. Preventive Services Task Force recommendations and the European guidelines, to broaden screening ages and aims to detect breast cancer earlier, especially as incidence rates rise among younger women. This initiative will be phased in over five years. ❤️🩹This decision reflects a commitment to enhancing women’s health across the region BUT will significantly increase hospital activities, necessitating additional resources. 💫At The Blue Box Biomedical Solutions we aim to solve this problem, building a device easy to use, that gives a rapid diagnostic, in a pain-free and radiation-free manner, and that decrease the diagnostic cost and the resources needed in the medical community! https://lnkd.in/dvWudFsU #BreastCancer #Screening #Innovation #HealthTech #WomenHealth #MedTech #IVD
Catalunya avanzará a los 45 años las mamografías de prevención del cáncer de mama
elperiodico.com
-
😁 Big news!! We've completed the pre-analytical phase with our final prototype - The Blue Box 5.0 Our Lab Technician Silvia Bueno Megias, our Lab Assistant Pol Estanyol i Zabala, and our Scientific Lead Júlia Solana Balaguer, PhD have done an incredible job testing and analyzing the device under different conditions such as temperature, sample volume... among others. 💪 Our team's hard work has brought The Blue Box one step closer to our journey towards #CEmark and we are very excited about it! #BreastCancerAwareness #EarlyDetection #MedicalInnovation #preanalysis #LabMilestones #ResearchMilestones #PreAnalyticalJourney 📍 Cosymbio
-
It's The Blue Box Greater Week! From May 13th to 18th, the President of the United States declared Women’s Health Week. 👏 We highly commend these initiatives; they will help address the shocking gap in research and investment in women's health-related issues, and we need to do something about it. 💪 ⬇️ Check out the thoughts of some leaders on this matter: #NYSE #womenshealthsummit #womenmatter #womenhealthmatter
We asked leaders at the NYSE Women's Health Summit to explain what women's health means to them. Their answers provide a powerful reminder -- that when more women have a seat at the table, we can make more advancements in key areas, including women's health.
-
🩺🔵 Our CSO Júlia's take on the critical gap in #breast #cancer #screening.
✨ Exciting Update in Breast Cancer Screening Guidelines ✨ The U.S. Preventive Services Task Force has recently updated its guidelines for Breast Cancer Screening, now recommending biennial screening mammography for women aged 40 to 74 years. This is aligned with other organizations: The American College of Radiology, the Society of Breast Imaging, the American College of Obstetricians and Gynecologists, and the NCCN, that also advocate for initiating mammography screening at age 40 for women at average risk. 🤔 However, no specific recommendations for dense breasts have been made, stating that “the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening using ultrasound or MRI”. 🔎 As we celebrate progress in breast cancer screening, it’s imperative to address the disparities and challenges faced by women with dense breast tissue. 👩🔬 At The Blue Box Biomedical Solutions we are working to face this challenge, offering a non-invasive and highly accurate method for detecting breast cancer, unaffected by breast density. We aim to facilitate earlier detection for all women, regardless of breast density. 🗣️💬 What other steps can we take to overcome the limitations of dense breast tissue in cancer screening? How can we advocate for greater inclusivity and accessibility in screening programs? Feel free to share your insights! 🖇 Articles Links: - https://lnkd.in/dy93fhSF. https://lnkd.in/dDNPAWji /
-
👀🔦 Check out our current job opening for Tech Lead and take the first step toward an exciting career with us. ➕ Feel free to share this post with anyone you think would be a great fit! #hiring #techlead #technologylead #medicaldevices #healthindustry #talent ⬇️TECH LEAD application form https://lnkd.in/e4NAGcQ7
-
The Blue Box Biomedical Solutions ha compartido esto
📢Exciting News from The Blue Box Biomedical Solutions! We are thrilled to announce that The Blue Box is one of the 16 companies selected to join the inaugural cohort of the CancerX Accelerator. This landmark program is a key component of the U.S. CancerX Moonshot initiative, backed by The White House to drive forward cancer prevention and early detection. 🏆This means that The Blue Box has been recognized by the highest levels of government for our innovative approach to breast cancer screening. Our technology, which allows women to detect breast cancer using just a urine sample, is setting a new standard in early detection and accessibility. With our participation in CancerX, we will enhance our capabilities to develop and scale our solution, contributing to the broader goal of improving Breast Cancer cancer outcomes through early detection - a cornerstone of the Biden Cancer Moonshot’s recent efforts. 👇To learn more about CancerX and how it’s shaping the future of cancer care, visit: www.cancerx.health and https://lnkd.in/djePjf_2. 🩵Our team is integrated by 8 people: CEO, CTO, COO, Clinical Lead, QA/RA Manager, Project Manager, Lab Technician, and R+D Engineer. Meet part of our team here: https://lnkd.in/dDaNhTcp #CancerX #CancerMoonshot #BreastCancer #HealthTechInnovation #TheBlueBox #AI #TheWhiteHouse
Páginas similares
Buscar empleos
Financiación
Última ronda
Semilla540.631,00 US$
Inversores
Grow Venture Partners